A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma-Reference-Cited by-同舟云学术

A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma

Published:2014-10-22 Issue:24 Volume:20 Page:6304-6313
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wick Wolfgang,Fricke Harald,Junge Klaus,Kobyakov Grigory,Martens Tobias,Heese Oliver,Wiestler Benedikt,Schliesser Maximilian G.,von Deimling Andreas,Pichler Josef,Vetlova Elena,Harting Inga,Debus Jürgen,Hartmann Christian,Kunz Claudia,Platten Michael,Bendszus Martin,Combs Stephanie E.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Randomized Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy of 25 Gy in 5 Fractions Compared With 35 Gy in 5 Fractions in the Reirradiation of Recurrent Glioblastoma;International Journal of Radiation Oncology*Biology*Physics;2024-07

2. Current status of precision oncology in adult glioblastoma;Molecular Oncology;2024-06-20

3. Treatment with the apoptosis inhibitor Asunercept reduces clone sizes in patients with lower risk Myelodysplastic Neoplasms;Annals of Hematology;2024-02-27

4. CAN008 prolongs overall survival in patients with newly diagnosed GBM characterized by high tumor mutational burden;Biomedical Journal;2023-09

5. Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity;Journal of Neuro-Oncology;2023-09